LITMUS Partners

Participant No * Partner name Country
1 UNEW Newcastle University (Coordinator) UK
2 AMC Academisch Medisch Centrum bij de Universiteit van Amsterdam Netherlands
3 ICAN Institute of Cardiometabolism and Nutrition France
4 APHP Hôpital Beaujon, Assistance Publique: Hôpitaux de Paris France
5 UMCM University Medical Centre Mainz Germany
6 UCAM University of Cambridge UK
7 ORU Örebro University Sweden
8 CIC Centre for Cooperative Research in Biosciences Spain
9 UBERN University of Bern Switzerland
10 UOXF University of Oxford UK
11 PERS Perspectum Diagnostics Ltd UK
12 SAS Servicio Andaluz de Salud Spain
13 NB Nordic Bioscience A/S Denmark
14 IBBL Integrated BioBank of Luxembourg Foundation Luxembourg
15 UNITO University of Torino Italy
16 UA University of Angers France
17 UZA Antwerp University Hospital Belgium
18 LIU Linköping University Sweden
19 UHEL University of Helsinki Finland
20 UMCU University Medical Centre Utrecht Netherlands
21 NKUA National & Kapodistrian University of Athens Greece
22 FML Faculdade de Medicina da Universidade de Lisboa Portugal
23 UMIL Università degli Studi di Milano Italy
24 UNIPA University of Palermo Italy
25 UCSC Università Cattolica del Sacro Cuore Italy
26 UKW University Hospital Würzburg Germany
27 RWTH Universitätsklinikum Aachen University Germany
28 UNOT University of Nottingham UK
29 MUW Medical University of Vienna Austria
30 ANT Antaros Medical AB Sweden
31 BHAM University of Birmingham UK
32 IXS iXscient Ltd UK
33 FFUL Faculdade de Farmácia da Universidade de Lisboa Portugal
34 EASL European Association for the Study of the Liver Switzerland
35 GNFT Genfit SA France
36 ICPT Intercept Pharma Europe Ltd UK
37 OWL One Way Liver S.L. Spain
38 EXA Exalenz Bioscience Ltd Israel
39 LLY Eli Lilly and Company Ltd USA
40 PFE Pfizer Ltd USA
41 BI Boehringer-Ingelheim International GmbH Germany
42 SOMA SomaLogic Inc. USA
43 NOVO Novo Nordisk A/S Denmark
44 SAN Sanofi-Aventis Deutschland GmbH Germany
45 ELLE Ellegaard Göttingen Minipigs A/S Denmark
46 NOVA Novartis Pharma AG Switzerland
47 TAK Takeda Pharmaceuticals International GmbH Switzerland
Copyright © 2018 LITMUS Project

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 777377. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. Visit IMI.

The information contained in this website reflects only the author's view. Neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information it contains.